Syndax Pharmaceuticals Inc Logo

Syndax Pharmaceuticals Inc (SNDX): Eigentümerstruktur

Takani Score ?
37.9

Preis (29.10.2026)52W Hoch52W Tief
14,15 US Dollar25,59 US Dollar12,795 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
37,273 US Dollar10 2 0 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
88.610.02720,51 8,03

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Syndax Pharmaceuticals Inc
Mitarbeiter 298
Handelsplatz NASDAQ
Ticker Symbol SNDX
IPO Datum 2016-03-03
Adresse 730 Third Avenue, New York, NY, United States, 10017

Unternehmensführung

RangNamePosition
1Mr. Michael A. Metzger M.B.A.CEO & Director
2Mr. Keith Alan Goldan CPACFO, Treasurer & Principal Accounting Officer
3Mr. Luke J. Albrecht J.D.General Counsel & Corporate Secretary
4Mr. Steven ClosterChief Commercial Officer
5Dr. Nicholas A.J. Botwood B.Sc., MBBSHead of Research & Development and Chief Medical Officer
6Dr. Peter Ordentlich B.Sc., Ph.D.Co-Founder & Chief Scientific Officer
7Dr. Richard A. Heyman Ph.D.Co-Founder
8Dr. Michael Downes Ph.D.Co-Founder
9Sharon KlahreVice President of Investor Relations & Communications
10Ms. Averi PriceSenior VP of Legal & Chief Compliance Officer

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1BlackRock Inc10,10%0,13 Mrd. USD
2Kynam Capital Management, LP9,02%0,11 Mrd. USD
3The Goldman Sachs Group Inc6,56%0,08 Mrd. USD
4State Street Corp6,34%0,08 Mrd. USD
5Bank of America Corp4,53%0,06 Mrd. USD
6Vanguard Capital Management, LLC4,40%0,06 Mrd. USD
7Deerfield Management Co4,23%0,05 Mrd. USD
8Eversept Partners, LP3,13%0,04 Mrd. USD
9Geode Capital Management, LLC2,89%0,04 Mrd. USD
10Hood River Capital Management LLC2,87%0,04 Mrd. USD
11Kingdon Capital Management LLC2,80%0,04 Mrd. USD
12Franklin Templeton Inc2,56%0,03 Mrd. USD
13Millennium Management LLC2,30%0,03 Mrd. USD
14Vanguard Portfolio Management, LLC2,15%0,03 Mrd. USD
15UBS Group AG2,12%0,03 Mrd. USD
16Elmind Capital LP2,08%0,03 Mrd. USD
17BNP Paribas Investment Partners SA2,00%0,03 Mrd. USD
18Candriam Luxembourg S.C.A.1,90%0,02 Mrd. USD
19Soleus Capital Management, L.P.1,82%0,02 Mrd. USD
20Two Sigma Investments LLC1,77%0,02 Mrd. USD